Sodium-potassium-chloride cotransporters 1 and 2 (NKCC1 and NKCC2)

Sodium-potassium-chloride cotransporters 1 and 2 are integral membrane symporters responsible for the electroneutral transport of Na^+, K^+, and Cl^− across cellular membranes. NKCC1 is widely distributed in many tissues, strongly expressed in secretory epithelia, smooth muscle cells, and neurons, where it is crucial for fluid secretion, cell volume regulation, and neuronal chloride homeostasis. NKCC2 is restricted to the renal thick ascending limb of Henle's loop, where it mediates reabsorption of these ions from filtered urine, essential for water and salt balance and urine concentration. Both are essential for physiological regulation but also provide therapeutic targets for loop diuretics in cardiovascular and renal disease. NKCC1 is also increasingly targeted in neurological disorders for its role in modifying GABAergic signaling. Their activity is tightly regulated by phosphorylation and cell volume/osmotic status. Genetic mutations (especially in NKCC2) cause Bartter’s syndrome, while NKCC1 overactivity has implications in hypertension, neurological disease, and some cancers.

Other names

SLC12A2Na–K–Cl cotransporter 1cation-chloride cotransporter 1SLC12A1Na–K–Cl cotransporter 2cation-chloride cotransporter 2

Loop diuretics inhibit NKCC1 and NKCC2, blocking Na^+, K^+, and Cl^− cotransport. This results in increased natriuresis and diuresis, used to treat hypertension and edema. In neurological indications, inhibition of NKCC1 modulates neuronal Cl^− gradients, affecting GABAergic signaling.